White matter abnormalities in Alzheimer's disease: Implications for pathophysiology, diagnosis, and treatment
Ageing Research Reviews · 2026-10 · 121 · 103229
DOI: 10.1016/j.arr.2026.103229 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2026-10. Verfasst von Zhichun Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The Second Affiliated Hospital of Hainan Medical University, Haikou 570311, China; Department of Neurology and Institute of …. Hauptthemen laut MEDLINE: Alzheimer Disease, White Matter. Die Arbeit nennt 341 Literaturangaben. Gefördert von: Hainan Medical University, National Natural Science Foundation of China, Shanghai Key Basic Research Program.
Themen: Demenz
Abstract (Originalsprache)
White matter (WM) abnormalities have emerged as a critical element in Alzheimer's disease (AD) pathogenesis, shifting from their former status as a passive consequence to an active regulator of disease progression. Notably, microstructural WM alterations, detectable early via advanced neuroimaging techniques such as diffusion tensor imaging, frequently precede overt gray matter atrophy and cognitive decline, highlighting their potential as early initiating events in the AD pathological cascade. The origins of WM pathology are multifactorial, involving a complex interplay among β-amyloid (Aβ) and tau aggregation, energy dysmetabolism, neuroinflammation, vascular dysfunction, and cellular senescence. Importantly, we emphasize a paradigm-shifting perspective: WM degeneration acts not merely as a downstream outcome but as a key contributor of AD pathogenesis, capable of accelerating protein aggregation, amplifying neuroinflammation, and compromising neural plasticity. Given its early manifestation and close association with symptom onset, WM integrity has emerged as a sensitive and reliable biomarker for early AD detection and progression monitoring. Moving beyond diagnostics, the growing understanding of WM pathophysiology has unveiled a new frontier of therapeutic interventions aimed at myelin regeneration and WM protection. Despite persisting translational challenges, targeting WM integrity represents a pivotal avenue for developing disease-modifying therapies capable of slowing disease progression and improving clinical outcomes in patients with AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, The Second Affiliated Hospital of Hainan Medical University, Haikou 570311, China; Department of Neurology and Institute of Neurology, Ruijin Hospital affiliated to Shanghai Jiao Tong University…
- Department of Neurology, The Second Affiliated Hospital of Hainan Medical University, Haikou 570311, China.
- Department of Neurology and Institute of Neurology, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
- Department of Neurology, The Second Affiliated Hospital of Hainan Medical University, Haikou 570311, China; International Center for Aging and Cancer (ICAC), Hainan Medical University, Haikou 571199, China; Key Laborato…
Förderung
- Hainan Medical University
- National Natural Science Foundation of China
- Shanghai Key Basic Research Program
- Shanghai Jiao Tong University
- Natural Science Foundation of Hainan Province
Zitieren
APA
Chen, Z., Yang, K., Lin, F., Tang, W., Shi, Y., Zhou, S., Liu, J., & You, Y. (2026). White matter abnormalities in Alzheimer's disease: Implications for pathophysiology, diagnosis, and treatment. Ageing Research Reviews, 121, 103229. https://doi.org/10.1016/j.arr.2026.103229
Vancouver
Chen Z, Yang K, Lin F, Tang W, Shi Y, Zhou S, et al. White matter abnormalities in Alzheimer's disease: Implications for pathophysiology, diagnosis, and treatment. Ageing Research Reviews. 2026;121:103229. doi:10.1016/j.arr.2026.103229
BibTeX
@article{Chen2026,
author = {Chen, Zhichun and Yang, Kangyan and Lin, Feifei and Tang, Weiting and Shi, Yuxuan and Zhou, Sizhe and Liu, Jun and You, Yong},
title = {White matter abnormalities in Alzheimer's disease: Implications for pathophysiology, diagnosis, and treatment},
journal = {Ageing Research Reviews},
year = {2026},
volume = {121},
pages = {103229},
doi = {10.1016/j.arr.2026.103229}
}
EUVIMED